Smartphone-based Health Applications IBDsmart and Doc®

McCombie A. et al., A non-inferiority randomized clinical trial of the use of the smartphone-based health applications IBDsmart and Doc® in the care of IBD patients, Inflamm Bowel Dis, 2019

Highlights from this Publication

“Remote symptom and fecal calprotectin monitoring is effective and acceptable. It also reduces the need for face-to-face outpatient appointments.”

Health Canada License: 98903
US: Not available for sale in the US.